Robin Schmitz
Overview
Explore the profile of Robin Schmitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
356
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schmitz R, Tohme S, Geller D
Hepatobiliary Surg Nutr
. 2025 Feb;
14(1):111-113.
PMID: 39925896
No abstract available.
2.
Schmitz R, Manook M, Fitch Z, Anwar I, DeLaura I, Olaso D, et al.
Front Transplant
. 2024 Jul;
2:1230393.
PMID: 38993898
Introduction: One-third of HLA-incompatible kidney transplant recipients experience antibody mediated rejection (AMR) with limited treatment options. This study describes a novel treatment strategy for AMR consisting of proteasome inhibition and...
3.
Eze A, Eze A, Chime C, Chen F, Moris D, Schmitz R, et al.
Cureus
. 2024 Feb;
16(1):e51930.
PMID: 38333480
Megaduodenum is a rare clinical syndrome characterized by significant duodenal dilation, elongation, and hypertrophy. Given its rarity and nonspecific clinical manifestations, megaduodenum may be misdiagnosed, leading to delays in surgical...
4.
Schmitz R, Fitch Z, Manook M, Schroder P, Choi A, Olaso D, et al.
Kidney360
. 2023 Jan;
3(12):2116-2130.
PMID: 36591367
Preexisting donor-specific antibodies (DSA) to MHC antigens increase the risk of antibody-mediated rejection (AMR) in sensitized transplant recipients and reduces graft survival. Pretransplant desensitization with costimulation blockade and proteasome inhibition...
5.
DeLaura I, Schroder P, Yoon J, Ladowski J, Anwar I, Ezekian B, et al.
J Immunol Methods
. 2022 Sep;
511:113363.
PMID: 36174734
Background: Given the role of B cells in sensitization and antibody-mediated rejection pathogenesis, the ability to identify, isolate, and study B cells in vitro is critical for understanding these processes...
6.
Schmitz R, Lidsky M
Ann Surg Oncol
. 2022 Sep;
29(12):7248-7249.
PMID: 36109412
No abstract available.
7.
Ziogas I, Schmitz R, Moris D, Vatsaas C
Anticancer Res
. 2022 Jan;
42(2):629-639.
PMID: 35093860
Pancreatic neuroendocrine tumors (PNETs) arise from endocrine pancreatic cells and comprise 3-5% of pancreatic cancers. Surgical resection is the only potentially curative option for PNETs. Surgical candidates should be carefully...
8.
Landa K, Schmitz R, Farrow N, Rushing C, Niedzwiecki D, Cerullo M, et al.
HPB (Oxford)
. 2022 Jan;
24(7):1153-1161.
PMID: 34987008
Background: Standard of care for resectable pancreatic cancer is a combination of surgical resection (SR) and multiagent chemotherapy (MCT). We aim to determine whether SR or MCT is associated with...
9.
Gao Q, Davis R, Fitch Z, Mulvihill M, Ezekian B, Schroder P, et al.
Xenotransplantation
. 2021 Dec;
28(6):e12713.
PMID: 34951057
Porcine islet xenotransplantation is a viable strategy to treat diabetes. Its translation has been limited by the pre-clinical development of a clinically available immunosuppressive regimen. We tested two clinically relevant...
10.
Jelly E, Kwun J, Schmitz R, Farris A, Steelman Z, Sudan D, et al.
J Biomed Opt
. 2021 Sep;
26(9).
PMID: 34561973
Significance: The current gold standard for monitoring small intestinal transplant (IT) rejection is endoscopic visual assessment and biopsy of suspicious lesions; however, these lesions are only superficially visualized by endoscopy....